Abstract Body

Background

TNPO3 is an importin involved in the transport of splicing factors such as CPSF6 to the nucleus. CPSF6 binds to the HIV-1 capsid and facilitates its translocation to the nucleus. Limb-girdle muscular dystrophy dominant 2 (LGMDD2) is a very rare autosomal dominant genetic muscle disease characterized by a heterozygous deletion in the TNPO3 gene, which generates a mutated isoform with 15 additional amino acids. Previous in vitro studies suggest that the cells of these patients are resistant to HIV-1 infection. The aim of this study is to characterize the integration sites (IS) of the virus in the genome of these patients’ cells.

Methods

PBMCs from 8 LGMDD2 patients and 7 unaffected relatives were isolated, activated with CD3+CD28+IL-2 for 72 hours, and infected with 50 ng p24/million cells of NL4.3-Renilla. At 24 hours, viral replication was assessed by measuring luciferase activity (Promega), and genomic DNA was isolated, fragmented, and specific ligands were added for sequencing (NEB-Next UltraII FS-DNA Library Prep Kit). Libraries were generated by PCR for the specific amplification of 3’LTR/5’LTR and genomic DNA hybrid fragments which were sequenced on MiSeq (Illumina).

Results

Luciferase activity was 1942±1435 in patients and 3189±1305 in controls (p=0.103). Library sequencing from 5 patients and 4 controls allowed the identification of an average of 21.6 and 24.8 IS (p=0.6034), respectively. In patients, 70.1% of IS were found in genes compared with 83.3% observed in controls (p=0.014). Comparing the IS identified with data from ATAC-Seq experiments on activated CD4+ T lymphocytes (ENCODE Project), it was observed that proviruses integrated in genes located into accessible chromatin regions decreased to 46.1% in patients and to 64.4% in controls (p=0.031). Gene density of the regions in which the proviruses are integrated were slightly lower in patients (22.1 genes/Mb) compared with controls (25.7 genes/Mb; p=0.1247). The proportion of IS located in the lamin-associated domains (LAD) of the nucleus in patients was 30.2% in patients and 24.2% in controls (p=0.219). No IS were located in centromeres or telomeres in any of the participants.

Conclusions

The genetic mutation in TNPO3 observed in the cells of LGMDD2 patients appears to cause HIV-1 to decrease its preferential integration in genes, including those specifically located in accessible chromatin regions of activated CD4+ T lymphocytes, after 24 hours from infection, which may partly explain their resistance to infection.